Home / Companies / Rigel Pharmaceuticals, Inc. / 24 May 2024
Rigel Pharmaceuticals, Inc.: meeting of 24 May 2024
Votes reported on Form N-PX, item by item
180 Form N-PX filers reported votes at the Rigel Pharmaceuticals, Inc. meeting of 24 May 2024. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 96.7% of reported votes for; 4 filers withheld from or voted against at least one nominee.
246 vote records from 68 filers. 2 of the 68 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
255 vote records from 180 filers. 9 of the 175 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
123 vote records from 68 filers. 1 of the 68 filers that marked the item either way voted against management.
0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
123 vote records from 68 filers. 1 of the 68 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
123 vote records from 68 filers. 39 of the 68 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
123 vote records from 68 filers. 8 of the 68 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| State Street and SPDR | For | For | For |
| Franklin Templeton | For | For | For |
| Invesco | Split or no vote | For | For |
| Equitable | Against * | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | For | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | For | For | For |
| Russell Investments | For | For | For |
| Nationwide | For | For | For |
| Victory Capital | For | For | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | For | For | For |
| BNY Mellon | No report | For | No report |
| Principal | For | For | For |
| Pacific Life funds | For | For | For |
| Global X | For | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | For | For | For |
| Macquarie and Delaware Funds | For | For | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Rigel Pharmaceuticals, Inc. meeting?
180 Form N-PX filers reported votes at the meeting of 24 May 2024. On say-on-pay, 9 of 175 voted against management (5.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Rigel Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Rigel Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Rigel Pharmaceuticals, Inc. with a meeting date within three days of 24 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.